Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-20

Clinical Trial Update: Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing whether preoperative dexmedetomidine hydrochloride nasal spray improves awake sedation and postoperative awake status during br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine hydrochloride nasal spray (dexmedetomidine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING